Profit by knowlytics
Donald Trump’s announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be limited, citing India’s manufacturing cost advantage, US-based production facilities of several drugmakers and uncertainty over how and when the tariffs will be implemented.
Several midcap stocks have witnessed sharp corrections despite the index gains. We highlight 14 such stocks that have fallen 15-50% over the past six months.
Adani Power Q1 Results: The company’s board has approved a fundraising of Rs 15,000 crore through the issue of equity shares via QIP or other means.
Indian stock markets experienced a decline on Wednesday as tensions in the Middle East escalated. Crude oil prices surged above $92 a barrel, impacting investor sentiment negatively. Broader markets also slipped, with small and midcap indices showing losses. Several major banking and IT stocks contributed to the Sensex’s drop. Despite these challenges, some auto and…
A share gift from Indo-MIM founder and IIT Madras alumnus Krishna Chivukula is set to generate a Rs 112 crore windfall for the institute through the company’s IPO. IIT Madras will sell half its gifted stake via the OFS while retaining the remaining shares, preserving upside after the listing.
Anant Raj will demerge its data centre and cloud businesses into a separately listed entity, Ashok Cloud, enabling shareholders to directly participate in the digital infrastructure business. Eligible shareholders will receive two Ashok Cloud shares for every Anant Raj share held, subject to regulatory approvals and the record date announcement.
Cube Highways Trust InvIT raised Rs 1,687.5 crore from anchor investors ahead of its Rs 5,000-crore public issue opening on July 22. Backed by marquee institutional investors, the issue is a 100% offer for sale and provides exposure to a diversified portfolio of operational road infrastructure assets across India.
Canara Robeco Asset Management shares jumped after the company reported a strong Q1FY27, driven by robust revenue growth, improved profitability, and steady expansion in assets under management (AUM). Revenue from operations rose 20% YoY to ₹116.2 crore, boosting investor confidence and driving the stock higher.
HFCL shares have surged over 250% in six months, but Deven Choksey Research believes the rally is far from over. The brokerage initiated coverage with a Buy rating and a target price of Rs 362, citing defence, aerospace and AI-driven optical connectivity as the company’s next major growth engines.
Carnelian Asset Management & Advisors, founded by market veteran Vikas Khemani, received SEBI approval to launch its mutual fund business. The move will allow the firm to offer active and passive investment products across equity, debt and hybrid categories, expanding its presence beyond PMS, AIFs and offshore strategies.